{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:57:20Z","timestamp":1790600240486,"version":"4.1.0"},"reference-count":104,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Hypertrophic cardiomyopathy (HCM) is a genetically and phenotypically heterogeneous myocardial disease characterized by unexplained left ventricular hypertrophy and a broad spectrum of clinical manifestations, ranging from an asymptomatic phenotype to heart failure, atrial and ventricular arrhythmias, sudden cardiac death, and advanced heart failure. Accurate diagnosis and risk stratification therefore require complex assessment. Multimodality cardiovascular imaging provides complementary structural, functional, and tissue characterization that cannot be obtained using a single imaging technique. Transthoracic echocardiography remains the cornerstone of initial diagnosis, hemodynamic assessment, and longitudinal follow-up, while advanced echocardiographic techniques provide additional information regarding myocardial and left atrial mechanics. Cardiac magnetic resonance (CMR) has become central to phenotypic characterization and tissue assessment. Cardiac computed tomography offers complementary high-resolution anatomical information, particularly for coronary assessment and procedural planning, whereas nuclear imaging, provides insights into coronary microvascular dysfunction, myocardial perfusion, and selected phenocopies such as transthyretin cardiac amyloidosis. Multimodality imaging also facilitates differentiation of HCM from other conditions such as athlete\u2019s heart, hypertensive heart disease, and infiltrative cardiomyopathies. Integration of imaging biomarkers with clinical and genetic information may improve prediction of adverse outcomes. Thus, multimodality imaging should be regarded not as a collection of competing techniques but as an integrated framework for precision diagnosis, risk stratification, therapeutic planning, and longitudinal management of patients with HCM.<\/jats:p>","DOI":"10.3390\/diagnostics16193149","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:35:59Z","timestamp":1790595359000},"page":"3149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodality Imaging in Hypertrophic Cardiomyopathy: From Phenotyping to Precision Clinical Management"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0181","authenticated-orcid":false,"given":"Niya","family":"Mileva","sequence":"first","affiliation":[{"name":"SHATC Medica Cor, Riga 35, 7013 Ruse, Bulgaria"},{"name":"Medical University of Pleven, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayot","family":"Panayotov","sequence":"additional","affiliation":[{"name":"SHATC Medica Cor, Riga 35, 7013 Ruse, Bulgaria"},{"name":"Faculty of Public Health and Health Care, Ruse University \u201cAngel Kanchev\u201d, 7017 Ruse, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"ref_2","first-page":"e633","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_4","first-page":"e198","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"150","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.echo.2022.03.012","article-title":"Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: An update from the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography","volume":"35","author":"Nagueh","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.15420\/cfr.2025.14","article-title":"Multimodality Imaging in Hypertrophic Cardiomyopathy","volume":"12","author":"Escribano","year":"2026","journal-title":"Card. Fail. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","article-title":"Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy","volume":"1","author":"Maron","year":"2008","journal-title":"Circ. Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12574-017-0338-4","article-title":"Exercise stress echocardiography in hypertrophic cardiomyopathy","volume":"15","author":"Suzuki","year":"2017","journal-title":"J. Echocardiogr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-015-0174-5","article-title":"4D flow cardiovascular magnetic resonance consensus statement","volume":"17","author":"Dyverfeldt","year":"2015","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","article-title":"Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"Kalam","year":"2014","journal-title":"Heart"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","article-title":"Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy","volume":"6","author":"Puntmann","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: A test in context","volume":"67","author":"Sherrid","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjcard.2007.10.032","article-title":"Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"101","author":"Harrigan","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.hfc.2024.12.003","article-title":"PET imaging for cardiomyopathy challenges simplistic notions of ischemia and viability","volume":"21","author":"Johnson","year":"2025","journal-title":"Heart Fail. Clin."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1742-1241.2009.02127.x","article-title":"Left atrial remodelling in hypertrophic cardiomyopathy: Relation with exercise capacity and biochemical markers of tissue strain and remodelling","volume":"63","author":"Saura","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"935103","DOI":"10.3389\/fcvm.2022.935103","article-title":"Prognostic value of left atrial strain in heart failure: A systematic review and meta-analysis","volume":"9","author":"Jia","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ehjci\/jey181","article-title":"Prognostic value of left atrial strain in predicting cardiovascular morbidity and mortality in the general population","volume":"20","author":"Modin","year":"2019","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e034336","DOI":"10.1161\/JAHA.124.034336","article-title":"Cardiac magnetic resonance left atrial strain in the prediction of death, ischemic stroke, and heart failure","volume":"13","author":"Krittayaphong","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: Implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jcmg.2022.03.029","article-title":"Clinical characteristics and prognostic importance of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"15","author":"Lee","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2007.05.061","article-title":"Right ventricular involvement in hypertrophic cardiomyopathy","volume":"100","author":"Maron","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"132390","DOI":"10.1016\/j.ijcard.2024.132390","article-title":"Prognostic value of right ventricular involvement in hypertrophic cardiomyopathy: A systematic review and meta-analysis","volume":"413","author":"Figliozzi","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur. J. Echocardiogr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.21037\/jtd-22-182","article-title":"Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: A narrative review","volume":"14","author":"Guigui","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ehjci\/jeaf282","article-title":"Role of multi-modality cardiac imaging in the management of patients with hypertrophic cardiomyopathy in 2025. A Clinical Consensus Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC","volume":"27","author":"Cardim","year":"2026","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.echo.2024.02.010","article-title":"Obstruction in hypertrophic cardiomyopathy: Many faces","volume":"37","author":"Abbasi","year":"2024","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/echo.13878","article-title":"Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography","volume":"35","author":"Inciardi","year":"2018","journal-title":"Echocardiography"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"iii9","DOI":"10.1093\/ejechocard\/jep157","article-title":"Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management","volume":"10","author":"Williams","year":"2009","journal-title":"Eur. J. Echocardiogr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review of existing literature","volume":"12","author":"Mohananey","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"qyag007","DOI":"10.1093\/ehjimp\/qyag007","article-title":"Dynamic assessment of global longitudinal strain after isometric exercise to predict functionally significant coronary lesion","volume":"4","author":"Mileva","year":"2026","journal-title":"Eur. Heart J.-Imaging Methods Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/heartjnl-2015-308576","article-title":"Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy","volume":"102","author":"Reant","year":"2016","journal-title":"Heart"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"750139","DOI":"10.3389\/fcvm.2021.750139","article-title":"Cardiac imaging for the assessment of left atrial mechanics across heart failure stages","volume":"8","author":"Bandera","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10554-025-03597-2","article-title":"Clinical and prognostic impact of left atrial strain in non-ischemic cardiomyopathies","volume":"42","author":"Raafs","year":"2026","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mangia, M., D\u2019Andrea, E., Cecchetto, A., Beccari, R., Mele, D., and Nistri, S. (2024). Current and clinically relevant echocardiographic parameters to analyze left atrial function. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11080241"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jcmg.2022.10.019","article-title":"Myocardial Work Predicts Outcome in Asymptomatic Severe Aortic Stenosis: Subanalysis of the Randomized AVATAR Trial","volume":"16","author":"Banovic","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ehf2.13740","article-title":"Performance of non-invasive myocardial work to predict the first hospitalization for de novo heart failure with preserved ejection fraction","volume":"9","author":"Paolisso","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurheartj\/ehs016","article-title":"A novel clinical method for quantification of regional left ventricular pressure-strain loop area: A non-invasive index of myocardial work","volume":"33","author":"Russell","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"jeab289.276","DOI":"10.1093\/ehjci\/jeab289.276","article-title":"Myocardial work in hypertrophic cardiomyopathy\u2014A new non-invasive parameter for segmental myocardial function?","volume":"23","author":"Batzner","year":"2022","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.2019190651","article-title":"MRI T1 mapping in hypertrophic cardiomyopathy: Evaluation in patients without late gadolinium enhancement and hemodynamic obstruction","volume":"294","author":"Xu","year":"2020","journal-title":"Radiology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1055\/s-0034-1399546","article-title":"T1, T2 mapping and extracellular volume fraction (ECV): Application, value and further perspectives in myocardial inflammation and cardiomyopathies","volume":"187","author":"Roller","year":"2015","journal-title":"Rofo"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12968-022-00866-0","article-title":"T2 mapping in myocardial disease: A comprehensive review","volume":"24","author":"Gil","year":"2022","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1007\/s00330-022-08629-2","article-title":"State-of-the-art myocardial strain by CMR feature tracking: Clinical applications and future perspectives","volume":"32","author":"Xu","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjcard.2023.06.096","article-title":"Application of cardiovascular computed tomography to the assessment of patients with hypertrophic cardiomyopathy","volume":"205","author":"Crean","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_56","first-page":"163","article-title":"Cardiac magnetic resonance and computed tomography in hypertrophic cardiomyopathy: An update","volume":"107","author":"Oliveira","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2008.07.031","article-title":"Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: Results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial","volume":"52","author":"Budoff","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1097\/CM9.0000000000003781","article-title":"Emerging technologies for septal reduction therapy in hypertrophic cardiomyopathy","volume":"138","author":"Zhang","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.athoracsur.2008.01.061","article-title":"Mitral valve abnormalities in hypertrophic cardiomyopathy: Echocardiographic features and surgical outcomes","volume":"85","author":"Kaple","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"20230407","DOI":"10.1259\/bjr.20230407","article-title":"Cardiac imaging with photon counting CT","volume":"96","author":"Flohr","year":"2023","journal-title":"Br. J. Radiol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pradeep Kundur, S., Malik, A., and Sivalokanathan, S. (2025). The Utility of Nuclear Imaging in Hypertrophic Cardiomyopathy: A Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14072183"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","article-title":"Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy","volume":"47","author":"Olivotto","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e12656","DOI":"10.1111\/micc.12656","article-title":"Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact","volume":"28","author":"Fiarresga","year":"2021","journal-title":"Microcirculation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13139-020-00681-4","article-title":"Nuclear imaging for cardiac amyloidosis: Bone scan, SPECT\/CT, and amyloid-targeting PET","volume":"55","author":"Paeng","year":"2021","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/eurjpc\/zwag001","article-title":"Expanding our understandings of the exercise-induced cardiac remodelling: The \u2018recreational athlete\u2019s heart\u2019","volume":"33","author":"Pelliccia","year":"2026","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12055-025-02039-x","article-title":"Role of cardiac magnetic resonance imaging in the management of hypertrophic cardiomyopathy","volume":"42","author":"Rowin","year":"2026","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"ztaf143.142","DOI":"10.1093\/ehjdh\/ztaf143.142","article-title":"Basal septal curvature as a transformative imaging-based biomarker in hypertensive and metabolic heart diseases","volume":"7","author":"Sanver","year":"2026","journal-title":"Eur. Heart J.-Digit. Health"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.5646\/ch.2026.32.e14","article-title":"Cardiac magnetic resonance assessment of left ventricular phenotypes and prognostic implications in hypertensive heart disease","volume":"32","author":"Lertsiripatarajit","year":"2026","journal-title":"Clin. Hypertens."},{"key":"ref_73","first-page":"605653","article-title":"Apical Hypertrophic Cardiomyopathy Misdiagnosed as Hypertensive Heart Disease Due to Anchoring Bias in an African Man: A Case Report","volume":"19","author":"Okema","year":"2026","journal-title":"Int. Med. Case Rep. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamacardio.2026.0833","article-title":"Timeliness of transthyretin cardiac amyloidosis diagnosis in the medicare population","volume":"11","author":"Fan","year":"2026","journal-title":"JAMA Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e018991","DOI":"10.1161\/CIRCIMAGING.125.018991","article-title":"Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence","volume":"19","author":"Ioannou","year":"2026","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"jeaf367.426","DOI":"10.1093\/ehjci\/jeaf367.426","article-title":"Cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis in patients with heart failure","volume":"27","author":"Unger","year":"2026","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Graziani, F., Biagini, E., Argir\u00f2, A., Citro, R., Iaccarino, G., Lanzillo, C., Monte, I., Pieruzzi, F., Zuchi, C., and Pieroni, M. (2026). Cardiological aspects of Fabry disease: From diagnosis to therapeutic efficacy assessment. Orphanet J. Rare Dis.","DOI":"10.1186\/s13023-026-04485-1"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"134011","DOI":"10.1016\/j.ijcard.2025.134011","article-title":"Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)","volume":"444","author":"Camporeale","year":"2026","journal-title":"Int. J. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Sharshakova, A., Fattakhova, A., Solovyeva, V., Sufianov, A., Sufianova, G., Kutovoi, G., and Rizvanov, A. (2026). Pompe Disease: Pathogenesis, Molecular Mechanisms, Neurological Aspects, Diagnostics and Modern Therapeutic Approaches. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27083703"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Crea, P., Moncada, A., Catanzariti, F., Agnelli, G., Navarra, M., Rubino, C., Scim\u00e8, I., Teresi, L., Cusm\u00e0 Piccione, M., and Colarusso, L. (2026). Non-Lysosomal Glycogen Storage Cardiomyopathy with Hypertrophic Phenotype Due to PRKAG2 c.905G>A (p.Arg302Gln): Case Report and Narrative Review. Cardiogenetics, 16.","DOI":"10.3390\/cardiogenetics16010002"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"712.e1","DOI":"10.1016\/j.crad.2020.04.012","article-title":"Clinical features and cardiovascular magnetic resonance characteristics in Danon disease","volume":"75","author":"He","year":"2020","journal-title":"Clin. Radiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: Clinical features, evaluation, and management","volume":"7","author":"Levandowski","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_84","first-page":"385","article-title":"Mitochondrial cardiomyopathy: Pathophysiology, diagnosis, and management","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex. Heart Inst. J."},{"key":"ref_85","first-page":"50","article-title":"Cardiac sarcoidosis\u2014State of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2967\/jnumed.112.115121","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"55","author":"Schatka","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_88","first-page":"312","article-title":"The Long-Term Mortality Predictors in Hypertrophic Cardiomyopathy Patients with Low Risk of Sudden Cardiac Death","volume":"53","author":"Pay","year":"2025","journal-title":"Turk. Kardiyol. Dern. Ars."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Santoro, F., Mango, F., Mallardi, A., D\u2019Alessandro, D., Casavecchia, G., Gravina, M., Correale, M., and Brunetti, N.D. (2023). Arrhythmic risk stratification among patients with hypertrophic cardiomyopathy. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103397"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcmg.2012.11.011","article-title":"Role of CMR imaging in risk stratification for sudden cardiac death","volume":"6","author":"AlJaroudi","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12471-014-0593-1","article-title":"Imaging to guide ICD therapy: Beware what lies beneath","volume":"22","author":"Rijnierse","year":"2014","journal-title":"Neth. Heart J."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Selvanayagam, J.B., Cleland, J.G.F., Hillis, G.S., Pasupathy, S., Billot, L., George, K.E., Atherton, J.J., Berry, C., Tonchev, I., and Gianacas, C. (2026). Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial. JAMA.","DOI":"10.1001\/jama.2026.17078"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tcm.2026.02.004","article-title":"Septal reduction therapies for obstructive hypertrophic cardiomyopathy: Current strategies and evolving innovations","volume":"36","author":"Cui","year":"2026","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_95","first-page":"30","article-title":"Alcohol septal ablation in hypertrophic cardiomyopathy","volume":"2018","author":"Mateo","year":"2018","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_96","first-page":"35","article-title":"Surgical myectomy: Rationale and personalized technique","volume":"2018","author":"Kindi","year":"2018","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s43044-025-00652-0","article-title":"Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy","volume":"77","author":"Ogieuhi","year":"2025","journal-title":"Egypt. Heart J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e024656","DOI":"10.1161\/JAHA.121.024656","article-title":"Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter","volume":"11","author":"Masri","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s44348-025-00052-7","article-title":"Cardiac myosin inhibitors in hypertrophic cardiomyopathy","volume":"33","author":"Lim","year":"2025","journal-title":"J. Cardiovasc. Imaging"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12947-021-00261-2","article-title":"Artificial intelligence in echocardiography: Detection, functional evaluation, and disease diagnosis","volume":"19","author":"Zhou","year":"2021","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41569-025-01197-0","article-title":"Artificial intelligence-enhanced echocardiography in cardiovascular disease management","volume":"23","author":"Myhre","year":"2026","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pcad.2024.06.004","article-title":"The role of artificial intelligence in cardiovascular magnetic resonance imaging","volume":"86","author":"Aromiwura","year":"2024","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s11547-023-01658-x","article-title":"Radiomics applications in cardiac imaging: A comprehensive review","volume":"128","author":"Polidori","year":"2023","journal-title":"Radiol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e004228","DOI":"10.1136\/openhrt-2026-004228","article-title":"Future promise, current clinical ambiguity: A systematic review of machine learning algorithm outputs predicting risk of cardiovascular disease","volume":"13","author":"Phillips","year":"2026","journal-title":"Open Heart"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:58:15Z","timestamp":1790596695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":104,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["diagnostics16193149"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16193149","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}